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Cardiac surgery is performed in approximately 770,000 adults and 30,000 children in the United States of America annually. In this review we
outline the mechanistic links between post-operative myocardial stunning and the development of myocardial edema. These interrelated processes
cause a decline in myocardial performance that account for significant morbidity and mortality after cardiac surgery. Factors leading to myocardial
edema include hemodilution, ischemia and reperfusion as well as osmotic gradients arising from pathological change. Several members of the
aquaporin family of water transport proteins have been described in the myocardium although their role in the pathogenesis and resolution of
cardiac edema is not established. This review examines evidence for the involvement of aquaporins in myocardial water handling during normal
and pathological conditions.
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Interest in this area has been stimulated by the clinical
observation that cardiac performance is predictably diminished
after cardiac surgery. This phenomenon is known as myocardial
stunning and is largely responsible for low cardiac output syn-
drome. The resulting hypo-perfusion of important organs in-
cluding kidney and brain accounts for the majority of morbidity
in current adult and pediatric cardiac surgical practice.
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mitochondrial morphology and function [1,2]. It is well re-
cognized clinically, with a decline in cardiac performance seen
2–12 h following cardiac surgery [3]. The development of
myocardial edema during this period is not well reported but
does occur [4]. It is the primary cause of acute diastolic dys-
function, or impaired ability of the heart to relax during diastole,
necessitating higher filling pressures to generate satisfactory
cardiac output [5].
Most cardiac operations involve the use of cardiopulmonary
bypass (the ‘heart–lung machine’) which pumps oxygenated
blood to the body whilst the heart and lungs are isolated. The
conduct of cardiopulmonary bypass involves hemodilution, and
an inflammatory process is established as the blood flows across
the foreign surfaces of the extracorporeal circuit. These factors
combine to promote whole body water accumulation, much of it
in the interstitial space [6,7]. In addition, the heart suffers the
metabolic effects of ischemia and reperfusion. The generation of
intracellular lactate creates a strong inwardly directed osmotic
gradient that causes cardiomyocytes to swell and may impair
ventricular performance contributing to the clinical syndrome of
stunning [8].
In this review, we examine water transport in the normal
heart and how this may vary in pathological circumstances. We
pay particular attention to the potential role of trans-cellular
water movement mediated by aquaporins (AQPs) and an over-
view of this group of proteins is provided in Section I.
2. Section I—Aquaporins
AQP proteins form transmembrane channels which facilitate
movement of water molecules along osmotic gradients. There
are 13 AQPs, found in mammals (AQP0–12), most of which
permit transcellular passage of water while some also allow
passage of glycerol (AQP3, 7, 9 and 10). In some circum-
stances, heavy metal salts, chloride, CO2 and ammonia may
also be transported by aquaporins. Most AQPs display organ-
and cell-specific expression which sometimes differs between
species. Highly specific regional expression of different AQPs
combine to coordinate water movement in a number of organs.
For instance AQP1 expression in the proximal tubule of the
kidney facilitates the initial extraction of water to concentrate
urine. This process is an example of near-isosmolar water
movement driven by active solute transport. Later, in the prin-
cipal cells of the collecting duct AQP2 is sequestered within
vesicles which, in response to vasopressin receptor activation,
insert into the apical membrane to facilitate water reabsorption
into the tubular cell. Expression of AQP3 and 4 in the basolateral
membrane then allows the water to move into the hypertonic
interstitium of the medulla and finally to return to the circulation.
Much of our understanding of AQP function comes from
analysis of pathological situations. Within the brain, AQP4 is
integral to the blood brain barrier and is primarily responsible for
the development of cerebral edema following cytotoxic injury [9].
Thus, AQP4 knockout mice demonstrate significant survival
benefits compared to wild type mice following stroke and,
traumatic brain injury, with benefits also seen in meningitis andwater intoxication [9–12]. Conversely, AQP4 knockoutmice suffer
poorer outcome inmodels of vasogenic edema as thiswater channel
facilitates removal of water from the brain [13]. AQP4 is anchored
to the blood vessel-encapsulating astrocytic foot processes through
a protein complex involving syntrophin and dystrophin. In skeletal
muscle where the role of AQP4 is less well defined it is similarly
associated with the dystrophin protein complex. In the skeletal
muscle disease Duchene muscular dystrophy (DMD), AQP4
protein is reduced in association with absent dystrophin protein,
although this does not appear to primarily contribute to the muscle
weakness [14].
Information on mammalian AQP structure is based on ana-
lysis of AQP1. Monomers consist of 6 transmembrane helices
which form “hourglass” pores. In the cell membrane monomers
combine to form a tetrameric complex, although each monomer
is independently functional. Due to the design of the channel,
requiring reorientation of water molecules during transit, the
pore is highly specific to water and excludes H+ passage [15].
Water moves rapidly through AQPs, and the increase in per-
meability attributable to AQP4 is significantly greater than that
caused by AQP1 [16,17]. Gating of mammalian water channels
does not appear to be a consistent feature in studies thus far,
however pH and phosphorylation influenced permeability in
some cases e.g. pulmonary AQP3 permeability was reduced by
low pH [18] and Xenopus oocytes containing AQP4 had re-
duced permeability when phosphorylated [19]. Overall, AQP
function is largely subject to transcriptional, rather than short
term regulation by pH or other influences [20].
AQP1 is the ubiquitous water channel found in endothelial
cell membranes of vascular tissues throughout the body. It is
also found in the plasma membranes of the red blood cell,
kidney, lung, brain and eye [15]. It was the first AQP
discovered after being demonstrated in erythrocytes and
shown to permit rapid water permeability in response to an
osmotic gradient [21,22]. The study of AQP1 null individuals,
arising as a result of mutation in the AQP1 gene leading to
little or no AQP1 expression has provided an insight into the
function of AQP1 in humans. In these subjects, the
permeability of pulmonary endothelium was studied by
computerized tomography following a 3 l intravenous volume
load. Pulmonary venules of AQP1 null humans were engorged,
compared to control subjects that showed imminent interstitial
pulmonary edema in the form of peribronchiolar edema, the
thickness of the airway walls increasing by 40–50% [23]. It is
likely that this is due to a decrease in pulmonary vascular
permeability, as the study of AQP1 knockout mice, under
different conditions, has not revealed defects in alveolar or pleural
reabsorption, with no impairment in lung fluid or gas transport
physiology [24,25].
3. Section II—Myocardial water handling
Accumulation of excess interstitial fluid in the normal heart
is prevented by anatomical and physiological factors. As blood
traverses the myocardial capillary bed, it may leave via either
the coronary sinus, emptying into the right atrium, or via the-
besian veins that drain directly into the ventricular cavities. As
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easy passage or ‘run off’ is important. Any fluid that accumu-
lates in the interstitium is handled by myocardial lymphatics
which return water to the circulation via the thoracic duct.
The balance of microvascular fluid filtration is modeled by
the Starling forces, reviewed in detail by Melhorn et al. in the
context of myocardial fluid dynamics [4]. Many of the factors
driving water movement are affected during cardiac surgery
including the plasma colloid osmotic pressure, which is reduced
by hemodilution, and the compressive force of regular myocar-
dial contractions, which cease when the heart is arrested in di-
astole for the performance of the operation. These factors combine
to produce altered fluid filtration and a shift in the balance towards
accumulation of water in the interstitium.
When describing myocardial water permeability, most authors
are actually describing the net effect of water movement between
the vascular compartment and the interstitium. This is partly
determined by exposure of the interstitium to blood vessels,
essentially capillary density or surface area available for water
flux, which is very high in the heart compared to other organs.
Furthermore, the pore size determining permeability of these
microvessels is thought to be very high, combining to produce a
‘leaky’ endothelium compared to microvessels in other organs
[4]. Many investigators consider basal filtration rate through the
capillary to equal interstitial clearance of water through lymph
channels. It is not known how the cardiac microcirculation com-
pensates for chronic abnormalities of lymph flow as exist fol-
lowing cardiac transplantation, where connections to the thoracic
duct are severed, and in patients who have undergone total
cavo-pulmonary connections where elevated upper body venous
pressures may diminish lymph flow through the thoracic duct.
Broadly speakingwater traverses the cell membrane by one of 3
main routes: (i) by diffusion through the lipid bi-layer, (ii) coupled
to ion-channels or substrate transporters, such as glucose, Na+, K+,
Ca++ and (iii) via AQPs, which selectively permit rapid movement
of water in response to osmotic gradients [26].Water moves across
the lipid bi-layer bidirectionally in response to osmotic gradients as
a result of shifts in ionic and substrate concentrations. With regard
to water movement across the endothelium of the myocardium,
Kellen and Bassingthwaighte highlight the functional significance
of the inter-endothelial clefts as well as the aquaporins [27]. They
demonstrate that inter-endothelial cell clefts account for two thirds
of water movement across the capillary bed and into the interstitial
space, with a third passing through AQP water channels [28].
Water movement between the interstitium and intracellular
space has been relatively ignored compared to factors regulating
microvascular permeability. This may be because in normal
circumstances, cardiomyocytes are not subject to variations in
the extracellular osmotic environment. Intracellular water re-
presents approximately 77% of total tissue water [29] and
maintenance of interstitial and cardiomyocyte volumes are
inextricably linked through osmotically obliged water move-
ment. This may be clinically important in circumstances where
(i) interstitial fluid volumes are increased because of patholo-
gically increased microvascular permeability, such as cardio-
pulmonary bypass or sepsis, and (ii) when there is an inwardly
directed osmotic gradient as a result of cellular events such asischemia where accumulation of lactate osmotically draws water
into the cell during reperfusion [30].
The potential role of AQPs in the development of cardiac
edema has been explored in a number of species with differing
conclusions. The techniques used include video-microscopic
observation of osmotically induced changes in cell volume and
assessment of sarcolemmal water permeability by measuring
the rate of swelling or shrinkage. Together with an assessment
of the Arrhenius activation energy (Ea), which is a measure of
the energy barrier to water flux (normally high because dif-
fusion of water is limited by the lipid bi-layer) the contribution
of AQPs to net sarcolemmal water permeability can be estimated.
On the basis of these measurements, Ogura et al. showed that
AQPs represent a major route of water transport in guinea pig
and rat heart cells [31,32]. The inhibitory effect of adding Hg2+
(a non-specific AQP inhibitor) on interstitial fluid volumes
further confirmed these findings. Similar techniques were used
by Suleymanian and Baumgarten [33] in rabbit ventricular car-
diomyocytes. They demonstrated similar sarcolemmal permeabil-
ity but a higher Ea and concluded that diffusion, not water
channels, were the predominant path of water movement in the
rabbit. Species differences in AQP expression may explain this
discrepancy and the contribution ofAQPs to human cardiomyocyte
watermovement is, at present, unknown.Osmotic regulation of cell
volume affects a number of other sarcolemmal processes including
K+ channel activity with significant implications for cardiac
electrical activity [34] and susceptibility to arrhythmias [26].
In the unusual circumstance where there is an outwardly
directed osmotic gradient, as occurs during sepsis and after
cardiopulmonary bypass, endothelial AQPs are proposed to be
primarily responsible for the movement of water out of the
expanded interstitial space and into the capillary [28]. In several
non-cardiac tissues, such as brain [9,11,12] and cornea [35] the
involvement of AQPs in the development and resolution of
tissue edema has been demonstrated by comparative phenotype
studies using knockout mice. This provides a rational basis for
postulating a role of AQPs in cardiac edema.
4. Section III—Myocardial edema and stunning
Myocardial edema is often considered a secondary phenom-
enon and a downstream effect of the primary pathological process
such as myocardial ischemia, allograft rejection or systemic in-
flammatory process. In fact, myocardial edema causes organ
dysfunction that may persist long after the original insult and may
be more clinically relevant than the treated primary process.
Very small increases in myocardial fluid content are asso-
ciated with significant systolic ventricular dysfunction [36–46].
In one analysis, a 2.6% gain in myocardial water produced by
hypo-osmotic priming solutions for cardiopulmonary bypass
was associated with a 43% decline in left ventricular perfor-
mance and similar order reduction in compliance [43]. A second
study demonstrated a 30–50% decline in cardiac output for a
given preload when myocardial water content was increased by
3.5% [47]. Diastolic function is also compromised in associa-
tion with myocardial edema [30,42,46,48–50]. This is particu-
larly relevant in the pediatric setting following cardiac surgery,
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result of hypertrophy related to pre-existing structural lesions.
Myocardial edema also results from ischemia and reperfu-
sion injury [30,50,51]. In several species and models, cellular
edema is evident if the ischemic injury lasts more than 15 min
[8,30,50,51]. Swelling of organelles and in particular mitochon-
dria is an early event and accounts for the majority of cell
swelling. Mitochondria play a central role in myocardial stun-
ning. They are involved in preconditioning, liberation of re-
active oxygen species and potentially cell death. Initial movement
of water into mitochondria is thought to be part of the early
protective response to ischemia, countering the effect of matrix
shrinkage that increases the inter-membrane space and is dele-
terious to respiration [52]. In this context, water is thought to
move in response to an influx of K+ ions, as a result of mitoKATP
channel opening. Chemical openers of this channel, such as
diazoxide, have a cardioprotective effect however the pore-for-
ming proteins underlying this protective effect have yet to be
identified [53].
After reperfusion, swelling of cardiacmitochondria occurs due
to increased permeability of the inner mitochondrial membrane
and is probably driven by the osmotic effect of accumulation of
anionic proteins, monovalent cations, intermediates of the Krebs
cycle and other small organic molecules [54]. This occurs even
with the major ion channels closed, and is reversible with long
periods of reperfusion [55]. Again, the route by which water
travels in this setting is unknown. Excessive swelling may occur
with opening of the mitochondrial permeability transition pore
(mPTP) which allows non-selective movement of small mole-
cules. This leads to irreversible loss of the mitochondrial
membrane potential, uncoupling of the respiratory chain and
release of cytochromeC, initiating apoptotic or necrotic cell death
[2].
In the kidney the inner mitochondrial membrane contains
AQPs, possibly AQP8, that allows excessive swelling without
mPTP opening [56]. Chemical inhibitors of AQPs prevented
mitochondrial swelling, disruption and cell death. Thus inwardly
directed watermovement in mitochondria may be beneficial early,
then deleterious in subsequent stages of the mitochondrial res-
ponse to ischemia and reperfusion. Hepatic [57,58] and renal [56]
expression of mitochondrial AQPs has been reported, however
the functional significance of these findings has not been deter-
mined and attempts at localisation frustrated by poor antibody
specificity.
When the heart is subject to ischemia, cell swelling is of the
cytotoxic type, in response to accumulation of intracellular lactate.
Where ischemia is ‘planned’, as during cardiac surgery involving
cardiopulmonary bypass, there are other factors involved and there
will also be an element of vasogenic edema arising as a result of the
‘capillary leak syndrome’. This syndrome is well described fol-
lowing cardiac surgery, particularly in neonates and infants un-
dergoing corrective surgery for congenital heart disease. It has been
described as an ‘endotheliopathy’ and attributed to an increase in
vessel permeability, induced by a systemic inflammatory process
initiated by exposure of the blood to foreign surfaces of the car-
diopulmonary bypass circuit [59]. Excess capillary filtration and
reduced lymphatic clearance (as occurs when the heart is che-mically arrested [44]) may promote myocardial edema, and exag-
gerate the effect of ischemia by increasing the distance between
coronary arterial supply and cardiomyocyte [4]. Accordingly, an
edematous myocardium is associated with a greater energy re-
quirement to meet the demands of a less efficient contractile ap-
paratus [60].
The increase in total body water and tissue edema is coin-
cident with a predictable decline in cardiac output, leading many
to speculate that edema and poor cardiac output are causally
related [6,61,62]. In an acute study, the association between
edema and cardiac dysfunction is well demonstrated by ran-
domized treatment of infants following cardiopulmonary bypass
with modified ultrafiltration (MUF) which reduces plasma vo-
lume. Those undergoing MUF suffered less edema, measured as
myocardial wall thickness, and demonstrated improved con-
tractility compared to controls [63]. In adults, capillary leak
accounts for a 2–5% gain in extracellular fluid volume peaking
at 4 h post-cardiopulmonary bypass [6], again corresponding to
the peak of myocardial dysfunction [64,65].
The clinical importance of cardiac edema is highlighted by
the need to leave the child's sternum open after complex neo-
natal and infant cardiac procedures [66–68] often requiring
prolonged cardiopulmonary bypass. This is done to optimize
cardiac performance by reducing sternal compression. After the
systemic inflammatory response abates, interstitial fluid clears
and myocardial function improves, and the sternum may be
closed on the second or third postoperative day. Novel
treatments that reduce capillary leak or speed resolution of
interstitial edema would provide major clinical benefit.
5. Section IV—Aquaporins and the heart
The myocardial expression of AQPs is poorly characterized.
Soon after the initial description of AQP1, it was noted that the
cardiac microvasculature and the endocardium express this pro-
tein [69]. The abundance of AQP1 protein in cardiac tissue was
thought to reflect the dense vascular supply of this organ however
early reports suggested that water channels did not play a major
role in microvascular filtration in the heart [33] (discussed in
Section II). In normal circumstances, cardiomyocytes do not ex-
perience osmotic imbalance and to date, cardiac AQPs have not
been investigated with the same level of attention that renal and
brain AQPs have received.
A contemporary view of myocardial AQP expression would
include cells on both sides of the interstitial space, namely the
endothelial barrier as well as the sarcolemma of the cardiomyo-
cyte. Evidence of a functional role for AQP1 expression in
endothelial cells has been described in Section II [27,28,32].
Myocellular expression has been noted in rat cardiomyocytes
[70] with functional interactions demonstrated with caveolae in
response to changes in the osmotic environment. We have de-
monstrated AQP1 expression within t-tubules [71], themselves
invaginations of the sarcolemma extending into the myocardium
within the Z line structures (see Fig. 1). Ionic fluxes, particularly
relevant to Ca2+ homeostasis related to electromechanical cou-
pling and K+ in attenuating the cardiac action potential, may
require accompanying rapid osmotic equilibration.
Fig. 1. Expression of AQP1 in the heart. AQP1 is principally distributed in vascular endothelium. AQP1 is also present in membranes associated with the
cardiomyocyte, including the sarcolemma and associated invaginations, the t-tubules. Not shown in this depiction is AQP1 expression by red blood cells.
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cells, with the possibility that such interactions may also be
relevant in the heart. AQP4 has been shown to co-localise with
the Kir4.1 potassium channel in astrocyte endfeet [72] and this
interaction involves the dystrophin-associated proteins (DAP)
[73]. Loss of DAP integrity reduces AQP4 expression and the
clearance of extracellular potassium leading to seizures [17,74].
In the eye, co-localisation of Kir4.1, AQP4 and DAP have also
been demonstrated [75] and reduced expression of AQP4 and
Kir4.1 channels may contribute to proliferative retinopathy
following disruption to the retinal blood supply [76]. Thus a link
may exist between rapid K+ transport and water permeability at
the sarcolemma which impacts upon ionic balance and tolerance
of ischaemia. AQP4, Kir4.1 potassium channels and the DAP
complex are all present in the mouse heart although the role of
cardiac aquaporins in these processes have yet to be established.
Two reports describe myocardial AQP1 expression in di-
sease models. Jonker et al. demonstrated up-regulation of myo-
cardial AQP1 mRNA and protein expression in a model of
chronic fetal hypo-osmotic stress caused by hemodilution [77].
Immunohistochemistry showed AQP1 mostly within the vas-
culature and comparatively little within cardiomyocytes. It is
not known whether the observed increase in AQP1 expression
acts to increase interstitial edema or facilitates clearance through
movement of water back through endothelial cells into the
vascular compartment. The second study of AQP1 in a model of
clinical practice focused on the effect of cardiopulmonary by-
pass in the lamb [78]. In this study lambs underwent cardio-pulmonary bypass and deep hypothermic circulatory arrest with
6 h of reperfusion following which AQP1 mRNA levels were
unchanged. Deficiencies of this study include the small number
of animals in each group and utilization of operative techniques
now not commonly employed which may produce relatively
less inflammatory burden. AQP1 mRNA abundance was not
correlated with protein expression. It remains unclear what
effect cardiopulmonary bypass might have on expression of
AQP1 and how this would affect myocardial edema.
A number of AQPs in addition to AQP1 have been identified
in myocardial tissue. Those reported in human, sheep, rat and
mouse, searchable through the National Library of Medicine are
included in Table 1. Most reports have focused on the iden-
tification of relevant mRNA by PCR without correlation with
protein expression or site of expression. While many AQP
mRNAs are present in the heart, protein is detectable for only a
small few and AQP1 expression is both the most prominent and
functional in membrane permeability assays [79].
There are limited published data on human myocardial AQP
expression, other than AQP1. AQP3 transcript has been iden-
tified by RT-PCR [79] and previously by microarray, but with-
out positive staining by immunohistochemistry as shown for
other tissues in the study [80]. Absence of AQP3 in myo-
cardium has also been reported based on Northern analysis [81].
AQP4 mRNA has been identified by Northern analysis [82].
This finding was confirmed more recently by RT-PCR, but
further analysis revealed a lack of corresponding protein ex-
pression [79]. AQP4 is of particular interest due to the noted
Table 1
Myocardial aquaporin expression
Human Sheep Rat Mouse
AQP0
AQP1 present present present present
RT-PCR, IHC, Western-
endothelial & myocellular
distribution [71,79]
RNAse Protection
Assay [78]
IHC-endothelial &
myocellular
distribution [70]
Western [99]
Northern [96]
Northern, Western,
IHC-endothelial and
minimal myocellular
distribution [77]
RT-PCR, IHC, Western-
endothelial & myocellular
distribution [71,79]
RT-PCR, Western,
IHC [79]
Western, Northern &
autoradiography -endothelial [69]
Northern [96]
RNAse Protection Assay [97]
IHC-endothelial [98]
AQP2 absent absent absent
Microarray and IHC [80] RNAse Protection Assay [97] Northern [100]
RT-PCR [79] RT-PCR [79] RT-PCR [79]
AQP3 equivocal equivocal absent
present present RT-PCR, Western [79]
Microarray and IHC [80] RT-PCR, see ref. [79]
RT-PCR [79] absent
absent Northern [101,102]
Northern [81] RNAse Protection Assay [97]
Western [79] Western [79]
AQP4 equivocal equivocal present
present present Northern [103]
Northern [82] RT-PCR [79] RT-PCR, Western [79]
RT-PCR [79] absent
absent RNAse Protection Assay [97]
Western [79] Western [79]
AQP5 equivocal equivocal absent
present present Northern [105]
RT-PCR [79] RT-PCR, see ref. [79] RT-PCR, Western [79]
absent absent
Western [79] RNAse Protection Assay [97,104]
AQP6 absent present present
Northern [106] RT-PCR [79] RT-PCR [79]
RT-PCR [79]
AQP7 present present present
Northern [85,86] Northern [85,107] RT-PCR, Western [99]
RT-PCR [79] RT-PCR [79] RT-PCR [79]
AQP8 absent equivocal present
Northern [89] present Northern [108]
RT-PCR [79] Western [58] RT-PCR [79]
absent
Northern [87,88]
RT-PCR [79]
AQP9 equivocal present absent
present RT-PCR [79] RT-PCR [79]
RT-PCR [79]
absent
Northern [109]
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AQP10 equivocal N/A (pseudogene) absent
present Northern [112]
RT-PCR [79]
absent
RNAse Protection Assay [110]
Northern [111]
AQP11 present present present
RT-PCR [79] RT-PCR [79] Northern [113]
RT-PCR [79]
AQP12 absent
RNA dot blot [114]
Table 1 (continued)
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with the loss of dystrophin [83] and the cardiomyopathy oc-
curring with such diseases [84]. Human cardiac AQP7 mRNA
expression has been identified [79,85,86] and may be derived
from cardiac-associated adipose tissue where AQP7 is well
described, although it has been demonstrated in rat-derived iso-
lated cardiomyocytes [79]. Screens of human myocardial tissue
by PCR using degenerate primers based on the NPA motif com-
mon to many AQPs failed to demonstrate any novel AQPs in the
heart [71] although low levels of expression may limit the use-
fulness of this strategy. More recently an RT-PCR screen of
human myocardium using available primer sequences addition-
ally demonstrated mRNA for AQP5, 9, 10 and 11 [79].
Numerous AQPs have been found in the hearts of other species
(Table 1). AQP8 is reportedwithin themitochondrial fraction of rat
heart by Western blot [58] although is reportedly absent in this
species by RT-PCR [79] and Northern analysis [87,88]. AQP8
transcript is readily detectable by RT-PCR in the mouse heart [79].
Comparison of the permeability of heart-derived membranes of
wild-type and AQP8 knockout mice suggest that, even if present,
this protein is not functionally relevant in the heart [79]. However,
if AQP8 was confirmed as being both myocardial and mitochon-
drial in location, it may be of relevance to the study of ischemia,
reperfusion and the response of the cardiomyocyte to this injury. To
date, AQP8 has not been identified in human heart [89].
Finally, AQP1 may transport CO2 as well as water and this
may be beneficial to the heart during metabolic stress [90–92].
AQP1 expression inXenopus oocytes increases CO2 permeability
by 40% over controls and this increase is inhibited by blocking
AQP1 function with Hg2+ [91]. However physiologically
relevant CO2 transport via aquaporins could not be demonstrated
during both normal and stressed states in erythrocytes, lung and
kidney cells utilizing relevant knockout mouse materials, despite
water permeability being altered bymore than 100 fold [24,92–95].
Thus physiologically important CO2 transport by aquaporins with-
in the heart seems unlikely, but has not been directly studied.
6. Conclusion
Myocardial water handling likely involves AQP1 but the
importance of water movement mediated by this and other AQP
channels has yet to be defined in health and disease. Theconduct of cardiac surgery, particularly in children, involves a
series of potent stimuli for water retention. Myocardial edema is
a critical element of myocardial stunning and is responsible for
significant patient morbidity and mortality. Further character-
ization of AQPs in the heart will enhance our understanding of
the processes involved and may provide opportunities for
therapeutic intervention.
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